Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.

Hapgood, Janet P

Hapgood, Janet P.

Affiliation

Hapgood JP; Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.

AIDS Res Hum Retroviruses ; 36(5): 357-366, 2020 05.

Article in En | MEDLINE | ID: mdl-31797677

Subject(s)

Contraceptive Agents, Female/administration & dosage; Contraceptive Agents, Female/adverse effects; HIV Infections/etiology; Medroxyprogesterone Acetate/administration & dosage; Medroxyprogesterone Acetate/adverse effects; Adult; Contraception/methods; Female; Humans; Injections, Intramuscular; Male; Randomized Controlled Trials as Topic; Risk Factors

Key words

DMPA; Depo-Provera; ECHO trial; HIV; contraception

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Medroxyprogesterone Acetate / Contraceptive Agents, Female Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: AIDS Res Hum Retroviruses Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2020 Document type: Article Affiliation country: South Africa Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google